Gain Therapeutics Stock (NASDAQ: GANX) stock price, news, charts, stock research, profile.
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Other companies in Gain Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX) and Monopar Therapeutics (NASDAQ:MNPR).
Gain Therapeutics has a consensus price target of $8.00.
The stock price for Gain Therapeutics (NASDAQ: GANX) is $2.55 last updated October 31, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Gain Therapeutics.
Gain Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Gain Therapeutics.
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.